These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11518188)

  • 21. Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart.
    Bak MI; Ingwall JS
    Cardiovasc Res; 2003 Mar; 57(4):1004-14. PubMed ID: 12650878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.
    Linz WJ; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):239-46. PubMed ID: 14504689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects.
    Avkiran M; Marber MS
    J Am Coll Cardiol; 2002 Mar; 39(5):747-53. PubMed ID: 11869836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NHE inhibition does not improve Na(+) or Ca(2+) overload during reperfusion: using modeling to illuminate the mechanisms underlying a therapeutic failure.
    Roberts BN; Christini DJ
    PLoS Comput Biol; 2011 Oct; 7(10):e1002241. PubMed ID: 22028644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia.
    Toyoda Y; Khan S; Chen W; Parker RA; Levitsky S; McCully JD
    Ann Thorac Surg; 2001 Sep; 72(3):836-43; discussion 843-4. PubMed ID: 11565667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early signals after stretch leading to cardiac hypertrophy. Key role of NHE-1.
    Cingolani HE; Perez NG; Aiello EA; Ennis IL; Garciarena CD; Villa-Abrille MC; Dulce RA; Caldiz CI; Yeves AM; Correa MV; Nolly MB; Chiappe de Cingolani G
    Front Biosci; 2008 May; 13():7096-114. PubMed ID: 18508719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs.
    Gumina RJ; Buerger E; Eickmeier C; Moore J; Daemmgen J; Gross GJ
    Circulation; 1999 Dec 21-28; 100(25):2519-26; discussion 2469-72. PubMed ID: 10604890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium-Hydrogen Exchanger Isoform-1 Inhibition: A Promising Pharmacological Intervention for Resuscitation from Cardiac Arrest.
    Gazmuri RJ; Radhakrishnan J; Ayoub IM
    Molecules; 2019 May; 24(9):. PubMed ID: 31067690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model.
    Baartscheer A; Schumacher CA; van Borren MM; Belterman CN; Coronel R; Fiolet JW
    Cardiovasc Res; 2003 Mar; 57(4):1015-24. PubMed ID: 12650879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of the myocardium with sodium-hydrogen exchange inhibitors: A cardiac surgical perspective.
    Myers ML
    J Thromb Thrombolysis; 1999 Jul; 8(1):53-60. PubMed ID: 10481215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
    Gumina RJ; Daemmgen J; Gross GJ
    Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease.
    Karmazyn M; Gan XT; Humphreys RA; Yoshida H; Kusumoto K
    Circ Res; 1999 Oct; 85(9):777-86. PubMed ID: 10532945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Na+/H+ exchange inhibitors for ischemic diseases].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 2001 Dec; 118(6):363-70. PubMed ID: 11778453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
    Maczewski M; Beresewicz A
    Eur J Pharmacol; 2003 Feb; 461(2-3):139-47. PubMed ID: 12586209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
    Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
    J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1.
    Lee S; Yi KY; Hwang SK; Lee BH; Yoo SE; Lee K
    J Med Chem; 2005 Apr; 48(8):2882-91. PubMed ID: 15828827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic preconditioning and Na+/H+ exchange inhibition improve reperfusion ion homeostasis.
    Goldberg SP; Digerness SB; Skinner JL; Killingsworth CR; Katholi CR; Holman WL
    Ann Thorac Surg; 2002 Feb; 73(2):569-74. PubMed ID: 11845876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide).
    Chakrabarti S; Hoque AN; Karmazyn M
    J Mol Cell Cardiol; 1997 Nov; 29(11):3169-74. PubMed ID: 9405190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient expression of Na+/H+ exchanger isoform NHE-2 in LLC-PK1 cells: inhibition of endogenous NHE-3 and regulation by hypertonicity.
    Singh G; Orlowski J; Soleimani M
    J Membr Biol; 1996 Jun; 151(3):261-8. PubMed ID: 8661513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.